On March 5, 2024, CVS Health Corporation, a company listed on the New York Stock Exchange under the ticker CVS, filed a Form 8-K with the SEC. The report announced that CVS Health's senior management team, including Executive Vice President and Chief Financial Officer Tom Cowhey, will engage with investors and participate in a webcast at 9:50 a.m. Eastern Time. During these interactions, the management team will reaffirm the company's full-year 2024 financial guidance, which includes a GAAP diluted EPS of at least $7.06, an Adjusted EPS of at least $8.30, and a cash flow from operations of at least $12.0 billion. Additionally, Mr. Cowhey will provide updates on recent business trends and initiatives. The webcast will be available on the CVS Health...Show More

On March 5, 2024, CVS Health Corporation, a company listed on the New York Stock Exchange under the ticker CVS, filed a Form 8-K with the SEC. The report announced that CVS Health's senior management team, including Executive Vice President and Chief Financial Officer Tom Cowhey, will engage with investors and participate in a webcast at 9:50 a.m. Eastern Time. During these interactions, the management team will reaffirm the company's full-year 2024 financial guidance, which includes a GAAP diluted EPS of at least $7.06, an Adjusted EPS of at least $8.30, and a cash flow from operations of at least $12.0 billion. Additionally, Mr. Cowhey will provide updates on recent business trends and initiatives. The webcast will be available on the CVS Health Investor Relations website, with a replay archived for one year. The report also includes a reconciliation of the non-GAAP financial measure, Adjusted EPS, to the most directly comparable GAAP measure, which is projected GAAP diluted EPS. The adjustments include amortization of intangible assets and acquisition-related integration costs, particularly related to the acquisitions of Signify Health and Oak Street Health, as well as the tax impact of these adjustments.